Italy launches massive PrEP study to slash new HIV infections
Prevention
Recruiting now
This study will follow 5,000 HIV-negative adults in Italy who are taking PrEP, a daily pill that prevents HIV. Researchers want to see how well PrEP works in real life, how many people stick with it, and what barriers they face. The goal is to use this information to improve HIV …
Sponsor: Fondazione ICONA • Aim: Prevention
Last updated Jun 27, 2026 07:51 UTC